Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
Recruiting
N/A
Interventional Study
DCIS
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 84 (estimated)
- Sponsor
- Seoul National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In the case of a patient undergoing total mastectomy for intraductal carcinoma (DCIS), the sentinel lymph node is not excised during the primary surgery but only marked for identification. If the final histological examination confirms invasive cancer, delayed surgery is performed to remove the sentinel lymph node that was marked during the initial surgery.
primary endpoint : The success rate of …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 20 to 75 years old.
* Patients diagnosed with DCIS through histological examination.
* Patients undergoing mastectomy
Exclusion Criteria:
* In cases where the histopathological findings of the tissue examination indicate suspicious invasive lesions.
* In cases …
Contacts
No contact information available.